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This paper reports the case of a woman with uterine ﬁbroids and recurrent ascites, which were managed
by her clinical oncologist as peritoneal carcinomatosis, and treated with repeated tapping and immu-
notherapy. She was ﬁnally referred to a gynecologist who treated her with a laparoscopic hysterectomy
with bilateral salpingo-oophorectomy for severe anemia, aiming to remove her large ﬁbroid as well as to
exclude ovarian or uterine malignancy. Her symptoms disappeared after the surgery without recurrence
of ascites at 2 years' follow-up. Although disseminated malignant ascites can exist in a patient with ﬁ-
broids, clinicians should be aware of this rare pseudo-Meigs syndrome when no clinical evidence of
malignancy was conﬁrmed by investigations. Otherwise, it may mislead the diagnosis and management.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
When awoman of reproductive age presents with ascites, raised
cancer antigen (CA) 125, with or without pleural effusion, she
should be investigated extensively and managed with care. When
all investigations including computed tomography (CT), magnetic
resonance imaging (MRI), CT-positron emission tomography (CT-
PET), gastrointestinal workup, and peritoneal cytology reveal no
evidence of malignancy, Meigs or pseudo-Meigs syndrome should
be considered as a differential diagnosis. Although asymptomatic
ﬁbroids are commonly found during these investigations, physi-
cians not being aware of this unusual presentation may treat their
patient as a case of abdominal ascites or carcinomatosis with
repeated tapping, unorthodox treatment, and even chemotherapy.
To our knowledge, there is no similar report of mismanagement in
the literature, and therefore this case report is presented to high-
light this clinical entity in order to raise the awareness of this un-
common condition, which can be simply resolved by laparoscopic
myomectomy or hysterectomy.s of interest.
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A 43-year-old nulliparous woman presented with severe ane-
mia, malaise, and abdominal swelling for 18 months since April
2010. Her family history revealed that her mother died of uterine
cancer. Blood investigations evaluating levels of human chorionic
gonadotropin, carcinoembryonic antigen, and CA 19.9 were
normal. The only abnormal ﬁndings were severe iron-deﬁciency
anemia (5.6 g/dL) and elevated CA 125 (780 U/mL). Her chest X-
ray showed small amount of bilateral pleural effusions. CT scan
showed a large 76 mm  63 mm mass in the endometrial cavity of
the uterus and three small ﬁbroids measuring 2 cm. MRI showed a
large mass suggestive of a large submucosal ﬁbroid with degen-
eration in the central part of the uterine cavity. There was no
suspicious pelvic or para-aortic lymph node. Both CT and MRI
showed the presence of gross ascites. Hysteroscopy and curetting
were performed to exclude endometrial carcinoma, which showed
a large submucosal ﬁbroid with no abnormal endometrial pa-
thology. Although she was managed and investigated by two gy-
necologists, she did not agree to undergo a hysterectomy because
of her infertility and the absence of uterine malignancy. She was
then referred to a medical oncologist in October 2011 for further
management of her ascites.
On further investigations, she had no other known cause to
account for her ascites. Her liver function tests remained normal
and the biochemical measurements were as follows: albumin,
3.5 g/dL; bilirubin, 0.6 mg/dL; glutamic oxaloacetic transaminase,ally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. Multiple ﬁbroids with a large submucous ﬁbroid found after hysterectomy.
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hydrogenase, 243 U/L. Both upper gastrointestinal investigation
and colonoscopy were normal. Despite having no clinical evi-
dence of malignancy, she was managed as a case of recurrent
peritoneal ascites with 10 repeated abdominal tapping since
October 2011, together with leuprorelin [gonadotropin-releasing
hormone analog (GnRH-a); 3.6 mg] IMI (intramuscular injection)
monthly for 3 months and weekly intraperitoneal infusion of
Gendicine (Shenyang Xiehe Bio Pharmaceutical Co., Ltd, She-
nyang, China; a p53 gene therapy) for seven doses. All ascitic
ﬂuids from the abdominal tapping were negative for malignancy.
Initially, there appeared to be some improvements in her
abdominal distension, but a CT-PET scan in November 2011
showed a mild F-18 ﬂuorodeoxyglucose (FDG) uptake in the
uterus. The impression was a uterine ﬁbroid with degeneration,
while sarcomatous transformation could not be excluded. There
was no signiﬁcant FDG uptake elsewhere in the whole body. As a
result, she was referred to a gynecologic oncologist for a hys-
terectomy because of the persistent gross ascites due to sus-
pected uterine malignancy. She was offered a laparoscopic
hysterectomy with bilateral salpingo-oophorectomy as a less-
invasive approach for her condition.
At the time of laparoscopy, there were yellowish ﬁbrinous de-
posits with dark brown ascitic ﬂuid, but no tumor seedlings were
found (Fig. 1). The uterus was uniformly enlarged to 14 gravid
weeks. Laparoscopic hysterectomy and bilateral salpingo-
oophorectomy were performed uneventfully without complica-
tion. Multiple peritoneal samplings were taken from the ﬁbrin
deposits and the bloodstained peritoneal nodules. A frozen section
of the uterus revealed a large degenerative ﬁbroid with no
malignancy.Fig. 1. Laparoscopic pictures of the ﬁbrinous adhesion,The parafﬁn section pathology reconﬁrmed ﬁve small ﬁbroids
and one large 8-cm submucosal ﬁbroid with extensive degenera-
tion (Fig. 2). Ovaries with fallopian tubes were covered with
extensive serosal adhesions and focal endometriosis, but there was
no evidence of malignancy. All peritoneal lesions showed endo-
metriosis with an old hemorrhage, ﬁbrosis, and chronic inﬂam-
mation. There was no pathological evidence of malignancy or
peritoneal tuberculosis.
She recovered well after her operation and was discharged
home on Day 2 after the operation. She did not have any evidence of
recurrent ascites since after her operation 2 years ago.dark brownish ascetic ﬂuid, and enlarged uterus.
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Meigs syndrome is a benign condition ﬁrst described as a
combination of ﬁbroma or ﬁbroma-like tumor, ascites, hydrotho-
rax, with the ascites and hydrothorax resolving after the resection
of the tumor.1 In 1954, Meigs2 proposed to restrict the term “Meigs
syndrome” to benign and solid ovarian tumors accompanied by
ascites and hydrothorax. In 1934, Salmon3 described a similar as-
sociation of uterine ﬁbromatawith ascites and pleural effusion, and
this condition has subsequently been referred to as either “pseudo-
Meigs syndrome” or “atypical Meigs syndrome”. Since then, the
term “pseudo-Meigs syndrome” was used for other benign and
malignant pelvic tumors. In all these patients, pleural effusion and
ascites resolved after removal of the pelvic mass.
The pathophysiology of ascites and hydrothorax in Meigs syn-
drome remains uncertain and speculative. Meigs suggested that
irritation of the peritoneal surfaces by a hard, solid ovarian tumor
could stimulate the production of peritoneal ﬂuid. Samanth and
Black4 studied ovarian tumors accompanied by ascites and found
that only tumors > 10 cm in diameter with a myxoid component in
the stroma are associated with ascites. They believed that the ﬂuid
was secreted from the tumor as the source of the ascites. Other
proposed mechanisms were direct pressure on surrounding lym-
phatics or vessels, hormonal stimulation, and tumor torsion. Many
authors believe that the release of various mediators (e.g., activated
complements, histamines, or ﬁbrin degradation products) from
these tumors would increase capillary permeability leading to as-
cites.5 Hydrothorax is probably secondary to the accumulated as-
cites ﬂuid, which ﬁnds its way through the diaphragmatic
apertures, intermuscular areolar tissues, and intercellular gaps to
the pleural cavity.
Although ultrasound of the pelvis, CT, MRI, and CT-PET scans are
helpful, they have to be carefully interpreted and correlated with
the clinical presentation. For any patient with ascites, pleural ef-
fusions should be investigated thoroughly. Once the effusions test
negative for malignancy, the possibility of a benign condition such
as Meigs syndrome or pseudo-Meigs syndromemay present with a
similar picture as carcinomatosis should be considered.4,5 It was
unfortunate that this condition was not in the mind of the medical
oncologist in this report prior to treating our patient for persistent
ascites or suspected carcinomatosis.
Tumor marker CA 125 is presented in many abdominal condi-
tions, and therefore an increased level of this marker does not
necessarily point to a malignant condition. Pseudo-Meigs syn-
drome is also known to be associated with elevated CA 125 levels
and has been widely reported.6,7 Because elevation of CA 125 level
is caused by mesothelial expression of CA 125 rather than the ﬁ-
broids itself, peritoneal inﬂammation as a result of release of cy-
tokines from the necrotic or degenerative ﬁbroid might cause the
elevated CA 125 level.
In the literature, many authors had already published reports of
uterine leiomyomas associated with hydrothorax and ascites.6,8e10
It was a great surprise that the clinical oncologist in this case did
not realize the condition when all investigations were negative for
malignancy. In this report, there had been a few mismanagements.
First, no treatment was offered to the patient to remove her sub-
mucous ﬁbroid, which was likely the cause of her severe anemia
and persistent ascites due to pseudo-Meigs syndrome. Second,
even if the patient wanted to preserve her fertility, a laparoscopic,
hysteroscopic, or abdominal myomectomy could have been offered
to conserve her uterus. Third, the diagnosis of pseudo-Meigs syn-
drome was not made prior to the repeated abdominal tapping,GnRH-a injections, and gene therapy in this patient. Retrospec-
tively, to investigate and treat the condition like persistent ascites
without the clinical awareness of this pseudo-Meigs syndrome
could be a serious mismanagement in the early stage of
management.
With the advance of minimally invasive surgery, it would be an
error not to proceed with a diagnostic laparoscopy to make a
deﬁnitive diagnosis with either laparoscopic-targeted biopsy or
ﬁne-needle cytology. When the pseudo-Meigs syndrome is in the
differential diagnosis, laparoscopic removal of ﬁbroids is a rela-
tively noninvasive treatment. However, there are increasing case
reports of pseudo-Meigs syndrome suggesting its association with
low-grade leiomyoma or leiomyosarcoma.11,12 Therefore, proper
counseling to patients with these conditions is of great importance
to avoid a histological surprise after surgical removal of the tumor.
The prognosis of pseudo-Meigs syndrome is extremely good, and
resection of the ﬁbroid tumor can lead to a complete resolution of
the ascites and hydrothorax with no recurrence. Considering the
good prognosis of pseudo-Meigs syndrome, prompt and accurate
diagnosis to differentiate the syndrome from disseminated carci-
nomatosis is strongly advisable.
The clinical interest in this pseudo-Meigs syndrome is obviously
related to the fact that it can be confused with malignant ovarian
neoplasm, carcinomatosis peritonei, or a malignant pleural effu-
sion. This case report will hopefully raise clinical awareness such
that patients can beneﬁt from minimally invasive surgery to
remove ﬁbroids or tumors prior to any aggressive treatment.
Conclusion
Despite the likelihood of disseminated malignancy in similar
presentations, clinicians should be aware of this uncommon
pseudo-Meigs syndrome; otherwise, it may mislead the diagnosis
and management.
References
1. Meigs JV, Cass JW. Fibroma of the ovary with ascites and hydrothorax with
report of seven cases. Am J Obstet Gynecol. 1937;33:249e266.
2. Meigs JV. Fibroma of the ovary with ascites and hydrothorax; Meigs' syndrome.
Am J Obstet Gynecol. 1954;67:962e985.
3. Salmon U. Benign pelvic tumors associated with ascites and pleural effusion.
J Mount Sinai Hosp N Y. 1934;1:169e172.
4. Samanth KK, Black 3rd WC. Benign ovarian stromal tumors associated with free
peritoneal ﬂuid. Am J Obstet Gynecol. 1970;107:538e545.
5. Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. The role of inﬂammatory cy-
tokines in Meigs' syndrome. Obstet Gynecol. 2002;99:917e919.
6. Amant F, Gabriel C, Timmerman D, Vergote I. Pseudo-Meigs’ syndrome caused
by a hydropic degenerating uterine leiomyoma with elevated CA 125. Gynecol
Oncol. 2001;83:153e157.
7. Mitrou S, Manek S, Kehoe S. Cystic struma ovarii presenting as pseudo-Meigs'
syndrome with elevated CA125 levels. A case report and review of the litera-
ture. Int J Gynecol Cancer. 2008;18:372e375.
8. Weise M, Westphalen S, Fayyazi A, Emons G, Krauss T. Pseudo-Meigs syn-
drome: uterine leiomyoma with bladder attachment associated with ascites
and hydrothoraxda rare case of a rare syndrome. Onkologie. 2002;25:
443e446.
9. Williamson JG, Patel D, Menzies DN. Leiomyomata of the uterus associated
with ascites and hydrothorax. J Obstet Gynaecol Br Commonw. 1972;79:
273e280.
10. Terada S, Suzuki N, Uchide K, Akasofu K. Uterine leiomyoma associated with
ascites and hydrothorax. Gynecol Obstet Invest. 1992;33:54e58.
11. Huang SE, Huang SC, Lee WY, Hsu KF. Pseudo-Meigs’ syndrome caused by
uterine smooth muscle tumor of uncertain malignant potential with low
vascular endothelial growth factor expression. Int J Gynecol Cancer. 2008;18:
851e853.
12. Marci R, Giugliano E, Carboni S, Martinello R, Patella A. Pseudo-Meigs’ syn-
drome caused by a uterine leiomyosarcoma: a new clinical condition. Gynecol
Obstet Invest. 2011;72:68e72.
